Rna Diagnostics Inc., a Canadian company with a patented platform technology providing real-time cancer therapy guidance, announced today the closing of a $5 million Series A financing. The funding was led by iGAN Partners and includes new and existing investors.
EXVIVO, ProteinQure and iBionics are participating in the Winter 2018 cohort of the Canadian Technology Accelerator (CTA) San Francisco – Life Sciences, an intensive program that offers Canadian companies the opportunity to expand their business in a global hub for the life sciences sector.
Thornhill Medical is a finalist in the Emerging Exporter Category at the 2018 Ontario Export Awards, which recognize leadership and success in exporting. Winners of the awards will be announced at a luncheon gala on November 20, 2018.
Joule, a Canadian Medical Association subsidiary, awarded Dr. Brian Courtney (CEO of Conavi Medical) a $80,000 grant to expand his work developing image guidance technologies used in minimally invasive procedures.
Focal Healthcare (OBIO Pre-CAAP 2015) announced it has received both FDA 510(k) clearance and Health Canada approval for its Fusion Bx™ 2.0 prostate biopsy solution, which is now available for sale in the United States and Canada.
Winterlight’s cognitive assessment detected significant improvement for treatment relative to placebo in Cortexyme's Phase 1B trial for Alzheimer’s disease using COR388; a bacterial protease inhibitor.
Think Research has successfully completed its planned capital raise of over $25 million to further their ability to enhance their product line, advance machine learning capabilities and continue expanding into new markets.